BC Week In Review | Apr 4, 2011
Company News

Aptiv Solutions supply/service news

Aptiv also hired Michael McKelvey as EVP and COO. McKelvey was formerly president and CEO at CRO eResearch Technology Inc. (Philadelphia, Pa.). Aptiv Solutions , Great Falls, Va.   Business: Supply/Service   New CRO Aptiv Solutions...
BC Week In Review | Sep 20, 2010
Company News

Addplan GmbH, Averion, ClinResearch GmbH, Fulcrum, Trio Clinical Research LLC deal

The companies merged to form a new entity to provide drug and device development services. The merger was led by a group of investors, including SV Life Sciences, The Halifax Group and the Comvest Group....
BC Week In Review | Jun 14, 2010
Company News

Fulcrum Pharma deal

Investment banks SV Life Sciences and The Halifax Group declared their previously announced cash offer to acquire Fulcrum for 5.85p per share unconditional in all respects. At June 9, the banks held about 163.4 million...
BC Week In Review | May 31, 2010
Company News

Fulcrum deal

Investment banks SV Life Sciences and The Halifax Group extended to June 2 from May 19 their previously announced offer to acquire Fulcrum at 5.85p per share in cash. At May 19, the banks held...
BC Week In Review | May 10, 2010
Company News

Fulcrum Pharma deal

Investment banks SV Life Sciences and The Halifax Group will acquire Fulcrum for 5.85p per share in cash, or about £11.6 million ($17.6 million). The price is a 73% premium to Fulcrum's close of 3.38p...
Items per page:
1 - 5 of 5
BC Week In Review | Apr 4, 2011
Company News

Aptiv Solutions supply/service news

Aptiv also hired Michael McKelvey as EVP and COO. McKelvey was formerly president and CEO at CRO eResearch Technology Inc. (Philadelphia, Pa.). Aptiv Solutions , Great Falls, Va.   Business: Supply/Service   New CRO Aptiv Solutions...
BC Week In Review | Sep 20, 2010
Company News

Addplan GmbH, Averion, ClinResearch GmbH, Fulcrum, Trio Clinical Research LLC deal

The companies merged to form a new entity to provide drug and device development services. The merger was led by a group of investors, including SV Life Sciences, The Halifax Group and the Comvest Group....
BC Week In Review | Jun 14, 2010
Company News

Fulcrum Pharma deal

Investment banks SV Life Sciences and The Halifax Group declared their previously announced cash offer to acquire Fulcrum for 5.85p per share unconditional in all respects. At June 9, the banks held about 163.4 million...
BC Week In Review | May 31, 2010
Company News

Fulcrum deal

Investment banks SV Life Sciences and The Halifax Group extended to June 2 from May 19 their previously announced offer to acquire Fulcrum at 5.85p per share in cash. At May 19, the banks held...
BC Week In Review | May 10, 2010
Company News

Fulcrum Pharma deal

Investment banks SV Life Sciences and The Halifax Group will acquire Fulcrum for 5.85p per share in cash, or about £11.6 million ($17.6 million). The price is a 73% premium to Fulcrum's close of 3.38p...
Items per page:
1 - 5 of 5